Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestyleJohnson & Johnson said the settlement covers about 76,000 claims (Reuters)Johnson & Johnson has announced a provisional settlement of an estimated $5.5 billion to resolve tens of thousands of lawsuits alleging its talc-based products caused ovarian cancer. This landmark agreement aims to conclude a contentious legal battle that has plagued the pharmaceutical giant for a decade, encompassing approximately 76,000 claims. For the settlement to become final, it requires acceptance from 95 per cent of the ovarian cancer claimants across state or federal jurisdictions. J&J's vice president of litigation, Erik Haas, stated the company believes the claims are “meritless” but is willing to settle to achieve “closure” and focus on its core mission. The company expects to pay $3billion in 2027, with further payments in 2028, though an attorney involved in negotiations suggests the total payout could exceed $7 billion. In fullJohnson & Johnson to pay $5.5bn settlement over baby powder lawsuitsMore bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Johnson & Johnson has offered to pay several billion dollars to resolve tens of thousands of lawsuits that allege its baby powder and talc products caused ovarian cancer.The…

NEW YORK: Johnson & Johnson said on Monday (Jul 27) it would pay US$5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause…

Johnson & Johnson will pay $5.5 billion to settle ovarian cancer claims. This landmark settlement covers nearly all remaining talc lawsuits against the company. The deal requires…